Stadler R, Luger T. Long term survival benefit after adjuvant treatment of high risk cutaneous melanoma with dacarbazine and low dose natural interferon alpha: a controlled, randomised, multicentre trial. Abstract 7516. Available at: http://www.asco.org/ac/1,1003,_12-002636-00_18-0034-00_19-0033046,00.asp. Accessed June 22, 2005.
2.
Powell A. HSPH joins battle over America's waistline. Harvard Gazette. June 2, 2005. Available at: http://www.news.harvard.edu/gazette/2005/06.02/01-diet.html. Accessed June 17, 2005.
3.
Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-1867.
4.
Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23:6365-6378.
5.
Yuan J, Lovejoy DB, Richardson DR. Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood. 2004;104:1450-1458.
6.
Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations that facilitate proliferation?Crit Rev Oncol Hematol. 2002;42:65-78.
7.
Augustin M, Bock PR, Hanisch J, et al. Safety and efficacy of the long-term adjuvant treatment of primary intermediate-to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum albumL.) extract: results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung. 2005;55:38-49.
8.
Mansky PJ, Grem J, Wallerstedt DB, Monahan BP, Blackman MR. Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanicaldrug interactions in cancer therapy. Integr Cancer Ther. 2003;2:345-352.
9.
Lee JK, Lee MK, Yun YP, et al. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol. 2001;1:1275-1284.
10.
Takei M, Tachikawa E, Hasegawa H, Lee JJ. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem Pharmacol. 2004;68:441-452.
11.
Nabeshima S, Murata M, Hamada M, Chong Y, Yamaji K, Hayashi J. Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine. Int Immunopharmacol. 2004;4:37-45.
12.
Kirkwood JM, Bender C, Agarwala S, et al. Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol. 2002;20:3703-3718.
13.
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum(St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807-1814.
14.
Vitiello B, Shader RI, Parker CB, et al. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. J Clin Psychopharmacol. 2005;25:243-249.
15.
Gastpar M, Singer A, Zeller K. Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a oncedaily dosage in comparison with sertraline. Pharmacopsychiatry. 2005;38:78-86.
16.
Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John&s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 2005;330:503-503.
17.
Bocci V, Pacini A, Muscettola M, Pessina GP, Paulesu L, Bandinelli L. The kidney is the main site of interferon catabolism. J Interferon Res. 1982;2:309-314.
18.
Bocci V, Pacini A, Bandinelli L, Pessina GP, Muscettola M, Paulesu L. The role of liver in the catabolism of human alphaand beta-interferon. J Gen Virol. 1982;60(pt 2):397-400.
19.
Cui Y, Ang CY, Beger RD, Heinze TM, Hu L, Leakey J. In vitro metabolism of hyperforin in rat liver microsomal systems. Drug Metab Dispos. 2004;32:28-34.
20.
Kubin A, Wierrani F, Burner U, Alth G, Grunberger W. Hypericin: the facts about a controversial agent. Curr Pharm Des. 2005;11:233-253.
21.
Johne A, Perloff ES, Bauer S, et al. Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. Eur J Clin Pharmacol. 2004;60:617-622.